SCHEMBL6317657

SCHEMBL6317657

O=C(O)c1c(-c2ccccn2)noc1NS(=O)(=O)Cc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLO1 Q04760 1/20 0.41
KDM4E B2RXH2 4/20 0.40
ALDH1A1 P00352 4/20 0.40
HPGD P15428 4/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
ACLY P53396 1/20 0.38
GABRA5 P31644 1/20 0.38
EDNRA P25101 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
MMP1 P03956 1/20 0.38
MMP2 P08253 1/20 0.38
MMP9 P14780 1/20 0.38
MMP8 P22894 1/20 0.38
MMP13 P45452 1/20 0.38
P4HTM Q9NXG6 1/20 0.37
MEN1 O00255 1/20 0.37
GAA P10253 1/20 0.37
HTT P42858 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6315506 0.91 GLO1 (0.40) GLO1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL6315769 0.84 L3MBTL1 (0.42) KDM4EALDH1A1HPGDSMN1; SMN2MEN1
SCHEMBL6316907 0.83 EDNRA (0.43) KDM4EGABRA5EDNRAP4HTMMEN1
SCHEMBL6324589 0.83 EDNRA (0.48) EDNRAP4HTM
SCHEMBL6316894 0.80 MAPK14 (0.53) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL6316237 0.78 HPGDS (0.47) KDM4EGAAHTT
SCHEMBL6321302 0.78 EDNRA (0.39) KDM4EALDH1A1HPGDSMN1; SMN2ACLY
SCHEMBL6315797 0.78 KDM4E (0.51) GLO1KDM4EALDH1A1EDNRAMMP2
SCHEMBL6317664 0.78 EDNRA (0.40) KDM4ESMN1; SMN2GABRA5EDNRA
SCHEMBL6324765 0.77 TP53 (0.50) KDM4EALDH1A1SMN1; SMN2CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050059657-A1 Aminoisoxazole derivatives active as kinase inhibitors PFIZER ITALIA S.R.L. (IT) 2005-03-17 US claimed
EP-1435948-A1 AMINOISOXAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS Pharmacia Italia S.p.A. (IT) 2004-07-14 EP claimed
WO-2003013517-A1 AMINOISOXAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS PHARMACIA ITALIA S.P.A. (IT) 2003-02-20 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050059657-A1 Aminoisoxazole derivatives active as kinase inhibitors MAP3K9, MAP3K19, MAP4K2 GLO1 4430/4885KDM4E 1382/4885ALDH1A1 4444/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.